11th Life Science Pitch Day at the IZB: Connecting Startups with Capital, Expertise and Industry Networks

Twelve selected start-ups and project teams presented their approaches to addressing diseases with high medical need

08-Jul-2026 - The Innovation and Start-up Center for Biotechnology (IZB), together with High-Tech Gründerfonds (HTGF) and with the support of Leaps by Bayer, Boehringer Ingelheim Venture Fund and MEDICE – The Health Family, hosted the 11th Life Science Pitch Day at the IZB. The well-established format once ...

AM acquires Sequence

Expanding life sciences engineering and CQV capabilities

08-Jul-2026 - AM Technical Solutions (AM), a global architecture, engineering, construction, and commissioning firm specializing in high-technology markets, announces the acquisition of Sequence, Inc., a leading engineering firm specializing in Process Design, Commissioning, Qualification, and Validation (CQV) ...

POWTECH TECHNOPHARM 2026: Competitive advantages through cross-industry exchange

25-Jun-2026 - Between 29 September and 1 October 2026, POWTECH TECHNOPHARM will bring together experts from a wide range of process industries in Nuremberg and create the ideal conditions for knowledge-sharing and innovation. As the gateway to technologies used in processing powders, solids and liquids, the ...

Closure of the Strait of Hormuz exacerbates cost pressure in the chemical industry

"Chemistry is struggling, pharma is preparing for even greater challenges"

29-May-2026 - The chemical-pharmaceutical industry got off to a weak start in 2026. Seasonally adjusted production fell by 2.8% in the first quarter. This was almost 6% lower than in the previous year. The main reason for this was the significant decline in pharmaceutical production after companies used ...

Syntegon posts record year in 2025 and aims for further growth

Revenue increased by 10% to EUR 1.75 billion vs. prior year, reaching a new record

17-Apr-2026 - Syntegon, a strategic lifecycle partner to the global pharmaceutical, biotech, and food industries, announced record results for fiscal year 2025. The strong performance was driven by the successful execution of its customer-focused growth strategy in structurally growing markets. Torsten ...

Chemicals still in trouble

Pharmaceuticals grow, chemicals continue to slow down

13-Mar-2026 - The situation in the German chemical and pharmaceutical industry remains tense in the final quarter of 2025. Despite a slight recovery among some industrial customers at the end of the year - triggered by a few large orders - the downturn in the chemical industry continued: production, prices and ...

Exyte acquires TTP Group to accelerate growth of Biopharma and Life Sciences business

The goal is to create a strong partner for the booming European biotechnology and pharmaceutical industry

10-Sep-2024 - Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, intends to acquire TTP Group ("TTP"), a leading firm in consulting and engineering for the pharmaceutical and chemical industry in Europe. TTP's portfolio encompasses a wide range of engineering services, ...

Drug shortages: These factors lead to supply bottlenecks in the pharmaceutical industry

Competition between generics manufacturers makes supply chains more vulnerable

31-Mar-2023 - In a recent study, Prof. Dr. Kai Hoberg (KLU), Prof. Dr. David Francas (University of Applied Sciences Worms) and Stephan Mohr (Frankfurt School of Finance and Management) looked into which conditions affect the availability of drugs in Germany. One key finding: while competition between generics ...

ACHEMA 2022 offers new impulses for the process industry

Final Report ACHEMA 2022

29-Aug-2022 - At ACHEMA 2022, the world's leading trade show for the process industry, over 2,200 exhibitors from more than 50 countries showcased the latest equipment and innovative processes for the chemical, pharmaceutical and food industries at the Frankfurt fairgrounds from 22 to 26 August. Whether it was ...

WACKER Strengthens Biologics Business by Acquiring US-Based Plasmid DNA Manufacturer Genopis

Expansion of WACKER's portfolio as a contract manufacturer for the pharmaceutical industry

04-Feb-2021 - The Munich-based chemical company WACKER is acquiring 100 percent of the shares in pharmaceutical contract manufacturer Genopis Inc. from Helixmith Co Ltd, Seoul (South Korea) and Medivate Partners LLC, Seoul (South Korea). WACKER signed a corresponding agreement. WACKER will continue Genopis' ...